Skip to content
Cell Point logo

Cell Point (India)

CELLPOINT NSE
₹14.10 No trade today
P/E
6.71
View as Markdown
MCP
Close 4 Nov 2026 ₹14.10 −4.05 −22.3% 1Y
Start ₹18.15

Key Fundamentals

SMERetailConsumer Services

Price-based figures as of · TTM

ROCE
5.53%
Debt to Equity
1.03
EPS (TTM)
₹2.10
Book Value
₹39.77
Market Cap
—
P/E (TTM)
6.71
P/B
0.35
ROE
0.08%
Dividend Yield
1.67%
EBITDA
₹10.80 Cr
52W High
₹21.10
52W Low
₹11.70
Volume
0

Peer Comparison

Consumer Discretionary › Retail › Speciality Retail

Cell Point peer comparison
Trent
₹3,060.0086.05₹1,62,418 Cr21.000.13%27.70%28.30%₹22,001 Cr₹1,909 Cr
Lenskart Solutions
₹689.70155.69₹1,18,542 Cr13.730.00%6.33%8.08%₹9,634 Cr₹668 Cr
Vedant Fashions
₹496.8031.28₹12,088 Cr6.151.56%18.80%22.80%₹1,456 Cr₹386 Cr
Aditya Birla Lifestyle Brands
₹73.7150.83₹8,845 Cr6.280.68%14.90%15.00%₹8,601 Cr₹176 Cr
Aditya Vision
₹520.2548.35₹6,764 Cr8.750.24%18.70%17.10%₹2,924 Cr₹139 Cr
V2 Retail
₹149.1330.50₹5,972 Cr6.030.00%23.70%19.50%₹3,428 Cr₹177 Cr
Aditya Birla Fashion & Retail
₹40.66—₹4,837 Cr0.850.00%−13.60%−3.76%₹8,371 Cr−₹845 Cr
Cell Point (this company)
₹14.106.71₹28 Cr0.351.67%0.08%5.53%₹148 Cr₹3 Cr
Median 8 companies₹322.9748.35₹7,804 Cr6.220.19%16.80%16.05%₹5,900 Cr₹177 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

51 Average

Data confidence 100/100

Category scores

Quality
52
Average
Returns, margins, earnings quality 22% weight
Valuation
65
Good
Cheap vs sector & own history 24% weight
Growth
62
Good
Sales & profit trajectory 9% weight
Financial Health
32
Poor
Solvency, leverage, coverage 9% weight
Momentum
40
Weak
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.38 times its book value

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 10.0% over past five years.
  • Company has a low return on equity of 0.63% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1243
OscillatorsBullish243
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
39.96
Neutral
MACD (12,26,9)
−0.16
Bearish
SMA (50)
15.60
Bearish
SMA (200)
16.02
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+9.96%
3Y+7.17%
1Y+13.92%

Net profit

Net profit growth by window
5Y−100.00%
3Y−100.00%
1Y−100.00%

Operating cash flow

Operating cash flow growth by window
5Y−12.94%
3Y−44.97%
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
5Y−0.81 pp
3Y−3.45 pp
1Y+0.57 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2020₹270 Cr
Mar 2021₹219 Cr
Mar 2022₹260 Cr
Mar 2023₹286 Cr
Mar 2024₹310 Cr
Mar 2025₹309 Cr
Mar 2026₹352 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020₹2.00 Cr
Mar 2021₹1.00 Cr
Mar 2022₹2.00 Cr
Mar 2023₹7.00 Cr
Mar 2024₹2.00 Cr
Mar 2025₹2.00 Cr
Mar 2026₹0.00 Cr

Half-yearly Results

₹ Cr
CELLPOINT half-yearly results, ₹ crore
Particulars Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
149
147
158
163
154
171
177
191
Expenses
140
138
153
159
149
168
173
185
Operating Profit
9
9
5
4
5
3
4
6
OPM %
6%
6%
2.9%
2.5%
3%
1.6%
2.4%
3.1%
Other Income
1
1
2
0
1
3
0
0
Interest
4
5
3
2
2
3
3
4
Depreciation
0
1
0
2
3
0
1
2
PBT
5
4
2
0
0
2
0
1
Tax %
28%
37%
28%
100%
28%
18%
26%
119%
Net Profit
4
3
2
0
0
2
0
0
EPS (₹)
2.85
2.07
0.9
0.01
0.12
1.09
0.1
−0.07

Profit & Loss

₹ Cr
CELLPOINT profit and loss, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
270
219
260
286
310
309
352
Expenses
261
211
249
268
301
302
342
Operating Profit
9
8
11
18
9
7
10
OPM %
3.5%
3.6%
4.2%
6%
2.8%
2.4%
2.9%
Other Income
1
1
1
1
2
4
1
Interest
6
6
8
9
6
5
7
Depreciation
2
1
1
1
2
3
3
PBT
2
1
2
10
3
3
1
Tax %
33%
46%
32%
32%
38%
20%
94%
Net Profit
2
1
2
7
2
2
0
EPS (₹)
1.17
0.5
1.2
4.93
0.9
1.21
0.03
Div. Payout %
0%
0%
0%
0%
28%
0%
0%

Balance Sheet

₹ Cr
CELLPOINT balance sheet, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
14
19
19
19
Reserves
10
11
12
6
53
56
56
Borrowings
29
39
52
56
49
45
77
Other Liabilities
16
15
18
19
13
19
18
Total Liabilities
56
65
83
95
134
138
169
Fixed Assets
19
19
19
18
33
37
56
CWIP
0
0
0
0
0
1
4
Investments
0
0
0
0
0
0
0
Other Assets
36
46
64
76
101
101
109
Total Assets
56
65
83
95
134
138
169

Cash Flow

₹ Cr
CELLPOINT cash flow, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
2
0
6
−7
−1
1
Investing
−1
−1
0
−3
−31
2
−28
Financing
1
0
5
−1
39
−7
26
Net Cash Flow
1
1
5
2
2
−6
−1
Free Cash Flow
0
1
−1
6
−24
−6
−25
CFO/EBITDA
26
39
5
42
−62
−9
19

Ratios

CELLPOINT financial ratios, annual
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
1
0
1
0
0
1
1
Inventory Days
31
50
63
70
75
86
78
Days Payable
19
19
21
18
12
19
16
Cash Conversion Cycle
13
31
42
53
63
68
63
Working Capital Days
7
−2
−10
−8
−2
12
18
ROCE %
—
16%
18%
26%
9%
5%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Cell Point insights

57 extracted metrics across FY20–FY26.

Shareholding Pattern

As of Jun 2026

  • Promoters 73.06%
  • Public 24.11%
  • Others 2.83%

No promoter shares pledged as of 14 Oct 2026

Change since Mar 2026

Documents

Frequently Asked Questions about Cell Point (India)

What does Cell Point (India) Ltd do?
Incorporated in 2001, Cell Point (India) Ltd trades in smartphones and other consumer durable electronic goods
Where is Cell Point (India) Ltd (CELLPOINT) listed?
Cell Point (India) Ltd trades as CELLPOINT on the NSE.
Which sector does Cell Point (India) Ltd belong to?
Cell Point (India) Ltd is classified under the Retail sector, in the Speciality Retail industry.
What is the PE ratio of Cell Point (India) Ltd?
Cell Point (India) Ltd trades at a PE ratio of 6.71 as of 4 Nov 2026, on earnings per share of ₹2.1, against a book value of ₹39.77 per share.
What is the 52-week high and low of Cell Point (India) Ltd?
Over the last 52 weeks Cell Point (India) Ltd has traded between ₹11.7 and ₹21.1 as of 4 Nov 2026.
Does Cell Point (India) Ltd pay dividends?
Cell Point (India) Ltd has a dividend yield of 1.67%.
What is the Return on Equity (ROE) of Cell Point (India) Ltd?
Cell Point (India) Ltd reported a return on equity of 0.08%. Its debt-to-equity ratio is 1.03.

Company Information

Incorporated in 2001, Cell Point (India) Ltd trades in smartphones and other consumer durable electronic goods

Website cellpoint.biz
Listed 28 Jun 2023
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CELLPOINT.md for Cell Point (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Retail stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month